Melanotan II + PT-141 — claim review
Two melanocortin receptor agonists marketed in combination for tanning and sexual function. We compare the claims against the UK regulatory position, the documented side-effect profile of Melanotan II, and the licensed alternatives.
What people claim about this stack
- “Safe sunless tanning with sexual-function bonus”
- “Better than Viagra without the prescription”
- “Boosts libido naturally”
- “Reduces skin cancer risk by replacing UV exposure”
Why this stack is popular online
The pairing combines two memorable benefits — tanning and libido — that overlap in target demographic and are heavily marketed on social media. The “research only” label allows sellers to ship product without engaging with regulated medicine routes, and the price point is attractive compared to private prescriptions.
Evidence for each individual compound
- Melanotan II: a synthetic cyclic α-MSH analogue. Documented effects include skin pigmentation, nausea, blood-pressure effects, and effects on moles. Not approved by any major regulator for cosmetic tanning. Evidence grade D; regulatory risk R.
- PT-141 (bremelanotide): the more targeted melanocortin derivative. Approved in the US for HSDD as Vyleesi. UK / EU regulatory position should be confirmed against current MHRA / EMA guidance.
Evidence for the combination
The combination has not been studied for safety in humans. Stacking two compounds acting on overlapping melanocortin receptors increases the chance of side effects rather than mitigating them.
UK regulatory considerations
- Melanotan II — treated as a POM by the MHRA on the basis of its pharmacological effects; sale to UK consumers for human use is unlawful.
- PT-141 / bremelanotide — UK licensing should be verified against the current MHRA position; do not assume parallel US approval.
- Clinics offering either as a treatment face the same regulatory and clinical-governance questions as for other unlicensed peptides.
Safety uncertainties
- Cardiovascular effects (blood pressure, heart rate) — documented and additive.
- Nausea, vomiting, and flushing — common with melanocortin agonists.
- Effects on existing moles — a concern with Melanotan II in particular. Anyone with melanoma risk factors should not use it.
- Identity, purity, and dose accuracy of grey-market product are unverified.
Sport / doping concerns
Athletes should verify status of either compound against the current WADA Prohibited List. Unlicensed melanocortin agonists fall within S0 by default if not listed elsewhere. Strict liability applies.
Red-flag claims
If you see wording like this on a seller, clinic, or social-media advert, treat it as a warning sign rather than a benefit.
“Safe sunless tanning — replaces UV”
Documented adverse effects exist; melanocortin agonists are not a substitute for sun protection. The MHRA has warned against use.
“Better than prescription sexual function medicines”
Comparative claims require comparative human data. Licensed alternatives exist for both ED and HSDD and should be discussed with a clinician.
“Natural because it stimulates your own melanocytes”
Pharmacological stimulation is not 'natural'. Effects on existing moles are a concern.
“No prescription needed — discreet UK shipping”
Sale to UK consumers for human use is unlawful for Melanotan II; the seller is signalling they're outside the regulated framework.
Claim vs evidence
| Claim | Evidence | Human evidence? | Regulatory concern | Safer wording |
|---|---|---|---|---|
| “Safe sunless tanning” | E | No | High | Documented adverse effects exist; no regulator has assessed Melanotan II as safe for cosmetic tanning. |
| “Reduces skin cancer risk” | E | No | High | There is no evidence Melanotan II reduces skin-cancer risk in humans, and mole-related concerns exist. |
| “Better than Viagra” | E | No | High | Licensed PDE5 inhibitors have robust evidence; comparison to Melanotan II / PT-141 stack is not supported. |
| “Combining them is safer than higher single doses” | E | No | High | Stacking increases the chance of side effects rather than mitigating them. |
Safer alternatives to discuss with a qualified clinician
- For erectile dysfunction: licensed PDE5 inhibitors (sildenafil etc.) under appropriate clinical assessment.
- For HSDD: assessment of underlying contributors; licensed options where indicated and available in your jurisdiction.
- For cosmetic tanning: self-tan products and sun protection — not pharmacology.
- For melanoma risk: dermatology review, not a melanocortin agonist.
Questions to ask a qualified clinician
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- What is the MHRA's current position on Melanotan II?
- What is the licensed status of PT-141 / bremelanotide in the UK?
- What licensed alternatives exist for ED or HSDD that I should consider first?
- What are the cardiovascular and skin-related side effects I should know about?
- If I have moles or family history of melanoma, what would you advise?
Frequently asked questions
- Is Melanotan II legal in the UK?
- The MHRA treats Melanotan II as a prescription-only medicine on the basis of its pharmacological effects, and it has no UK marketing authorisation. The MHRA has publicly warned the public against using it.
- Is PT-141 legal in the UK?
- PT-141 (bremelanotide) is approved in the United States as Vyleesi for HSDD in premenopausal women. UK / EU licensing has been more limited at the time of writing. Verify current MHRA / EMA status before drawing conclusions.
- Is combining them safe?
- Both compounds act on melanocortin receptors. Stacking creates additional cardiovascular, mole-related, and gastrointestinal exposure beyond either alone. The combination has not been studied for safety in humans.
- Are licensed alternatives for sexual dysfunction available?
- Yes — PDE5 inhibitors (such as sildenafil) for erectile dysfunction, and depending on jurisdiction, bremelanotide for HSDD. Speak to a GP or specialist about evidence-based options that fit your situation.
- What about tanning?
- There is no UK-approved 'tanning peptide'. Cosmetic tanning is best addressed by self-tan products and sun protection. Melanotan II carries documented side effects and is not a safe substitute for UV protection.